Addyi was first accepted because of the FDA in August 2015 to take care of hypoactive sexual desire dysfunction (HSDD) in premenopausal Women of all ages. That's just yet another way of claiming it boosts sexual intercourse travel (also called libido) in Ladies that have not achieved menopause.